Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL703226 | 0.71 | — | — | |
| SCHEMBL843469 | 0.66 | — | — | |
| SCHEMBL701809 | 0.65 | GLA (0.31) | — | |
| SCHEMBL22982398 | 0.63 | — | — | |
| SCHEMBL2360409 | 0.63 | — | — | |
| SCHEMBL24134004 | 0.61 | PKM (0.36) | HSD11B1PKMKMT2ASMN1; SMN2 | |
| SCHEMBL13464466 | 0.61 | HSD11B1 (0.36) | HSD11B1PKMLMNAKMT2ASMN1; SMN2 | |
| SCHEMBL25045908 | 0.58 | KMT2A (0.36) | HSD11B1PKMLMNAHSD17B10KMT2A | |
| SCHEMBL5712564 | 0.58 | HSD11B1 (0.40) | HSD11B1KMT2A | |
| SCHEMBL6860310 | 0.58 | HSD11B1 (0.34) | HSD11B1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030198891-A1 | Novel ester compounds polymers, resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198891-A1 | Novel ester compounds polymers, resist compositions and patterning process | ARCN1, H1-2, RER1 | HSD11B1 1154/4885PKM 2693/4885LMNA 1087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.